Clinical Trial Update: Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for pexelizumab in conjunction with angioplasty in acute myocardial infarction (APEX-AMI) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Pexelizumab (pexelizumab)

Snippet

Sponsor: Procter and Gamble | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED